Phone: +49 (0)345 27996330
Fax: +49 (0)345 27996332
Whether your product is in early development, clinical studies or is ready to be supplied to market, we are your partner of choice; we provide a comprehensive service from early cell line development up to market supply for Active Pharmaceutical Ingredients (API). Our technologies are based on microbial expression systems (E. coli, yeast), thus we are able to offer you the most suitable manufacturing system for your API.
Ulrike Fiedler, CEO